Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study | Zendy

AI Assistant Blog Pricing

Chemotherapy or endocrine therapy, first-line treatment for patients with hormone receptor-positive HER2-negative metastatic breast cancer in China: a real-world study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.